AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zognis H 150mg/12.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Ark Life Sciences Pvt Ltd

Salt Composition

Irbesartan (150mg) + Hydrochlorothiazide (12.5mg)

Overview Zognis H 150mg/12.5mg Tablet

Hypertan H 150mg/12.5mg tablets combine two active ingredients to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly raises the risk of strokes, heart attacks, and kidney disease. Hypertan H 150mg/12.5mg tablets can be taken with or without food; dosage is personalized based on individual response and health status. Consistent daily timing is recommended. Continue treatment as directed by your physician; discontinuation may increase cardiovascular risks. The formulation includes a diuretic, promoting increased urination. Therefore, avoid administration within four hours of bedtime. Regular use, even during asymptomatic periods, is crucial for optimal efficacy. High blood pressure often presents without noticeable symptoms. Dizziness is a common side effect; others include nausea, fatigue, diarrhea, indigestion, headache, and hypotension. Increased urination is an expected effect of the diuretic component (hydrochlorothiazide) and contributes to blood pressure control, not a side effect. While rare, other adverse reactions are possible. Hydrochlorothiazide may, in rare instances, elevate intraocular pressure, potentially causing irreversible eye damage if left untreated. Always review the accompanying patient information leaflet and report persistent or bothersome side effects to your doctor; dosage adjustment or alternative therapies may be considered. This medication is contraindicated during pregnancy and lactation. Consult your physician before use if you have pre-existing kidney, liver, cardiac, or diabetic conditions. Alcohol consumption can exacerbate hypotension and may increase the likelihood of side effects.

Uses of Zognis H 150mg/12.5mg Tablet

Elevated blood pressure

Major Benefits of Zognis H 150mg/12.5mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Zognis H 150mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be consumed with or without food, consistent timing is recommended.

Common Side effects of Zognis H 150mg/12.5mg Tablet:

  • Nausea
  • Taste change
  • Upset stomach
  • Diarrhea
  • Weakness
  • Dizziness
  • Headache
  • Glucose intolerance
  • Increased blood uric acid
  • Increased blood lipid level
  • Electrolyte imbalance
  • Decreased blood pressure

How to use Zognis H 150mg/12.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zognis H 150mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.

How Zognis H 150mg/12.5mg Tablet works:

Each Zognis H tablet (150mg/12.5mg) contains a dual-drug formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Zognis H 150mg/12.5mg tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Zognis H 150mg/12.5mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of Zognis H 150mg/12.5mg tablets appear compatible. Available human data indicate minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking Zognis H 150mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Zognis H 150mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Zognis H 150mg/12.5mg tablets are not recommended for individuals with severe kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should use Zognis H 150mg/12.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Zognis H 150mg/12.5mg Tablet :

Should you forget a Zognis H 150mg/12.5mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Zognis H 150mg/12.5mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Heart-related

FAQs on Zognis H 150mg/12.5mg Tablet

The combination medication Zognis H 150mg/12.5mg Tablet manages hypertension by controlling blood pressure. This dual-action formulation lowers the likelihood of stroke and myocardial infarction, effectively treating high blood pressure.
Follow your physician's instructions precisely when administering Zognis H 150mg/12.5mg Tablet. This medication is for oral consumption, typically once daily. Ingest the tablet with ample water; food is optional. Consistent daily timing is advised.
Should you forget a dose of Zognis H 150mg/12.5mg Tablet, administer it immediately upon recollection. If, however, your next scheduled dose is imminent, skip the missed dose and continue with your usual regimen. Avoid doubling the dose to compensate; doing so could heighten the risk of adverse reactions.
Blood pressure may noticeably decrease after approximately two weeks of taking Zognis H 150mg/12.5mg Tablets. Complete effectiveness may require up to four weeks. Consult your physician with any questions or concerns.
This medication poses a risk of harm or fatality to your developing fetus. Consequently, if you are pregnant or considering pregnancy, immediate consultation with your physician is crucial. They may prescribe an alternative medication to manage your hypertension.
Telmisartan and Zognis H 150mg/12.5mg Tablet are both antihypertensive medications. Zognis H 150mg/12.5mg Tablet, a newer agent, demonstrates comparable blood pressure reduction to Telmisartan. Its efficacy is matched by a favorable safety profile, exhibiting fewer adverse reactions.
Discontinuing Zognis H 150mg/12.5mg Tablet without consulting your physician is inadvisable, regardless of your perceived health status or blood pressure readings. Abrupt cessation could elevate your blood pressure, potentially raising your stroke risk.
Exceeding the prescribed dosage of Zognis H 150mg/12.5mg tablets can lower your blood pressure, potentially causing dizziness or fainting. Promptly contact your physician or obtain immediate emergency care at a local hospital.
Adopting a healthier lifestyle is crucial for optimal well-being while using Zognis H 150mg/12.5mg Tablet. A low-sodium diet and effective stress management techniques, such as yoga, meditation, or engaging hobbies, are recommended. Prioritizing sufficient nightly sleep contributes to stress reduction and blood pressure regulation. Ceasing smoking and alcohol consumption helps lower blood pressure and mitigates cardiovascular risks. Regular exercise and a balanced diet rich in whole grains, fresh produce, and low-fat options are also essential. Seek your physician's advice for personalized guidance to maximize the benefits of Zognis H 150mg/12.5mg Tablet and maintain overall health.
Zognis H 150mg/12.5mg Tab...
160
MRP 195
18% off